These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22871819)

  • 1. The challenge and paradox in serology RhD typing for blood donors and patients.
    Hyland CA
    Blood Transfus; 2013 Jan; 11(1):4-5. PubMed ID: 22871819
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
    Londero D; Fiorino M; Miotti V; de Angelis V
    Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.
    Kulkarni S; Kasiviswanathan V; Ghosh K
    Blood Transfus; 2013 Jan; 11(1):37-42. PubMed ID: 22871818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of DNA analysis to the quality assurance of reagent red blood cells.
    Storry JR; Olsson ML; Reid ME
    Transfusion; 2007 Jul; 47(1 Suppl):73S-8S. PubMed ID: 17593291
    [No Abstract]   [Full Text] [Related]  

  • 5. The concept of "confirmatory testing" of donors for ABO and RhD.
    Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2837-9. PubMed ID: 24024965
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of a mandatory donor RHD screening in Switzerland.
    Crottet SL; Henny C; Meyer S; Still F; Stolz M; Gottschalk J; Neuenschwander K; Taleghani BM; Gowland P; Frey BM; Fontana S; Hustinx H; Niederhauser C; Gassner C
    Transfus Apher Sci; 2014 Apr; 50(2):169-74. PubMed ID: 24679597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on detection of samples of Rh-weak D and Del].
    Wang XZ; Lan JC; Wu XH; Zhou HY; Liu WJ; Liu D; Qi CS; Zeng FQ; Du KQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):509-11. PubMed ID: 15972154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a rapid antenatal Rh test on laboratory testing.
    Smart EA; Milner LV
    S Afr Med J; 1993 Dec; 83(12):922. PubMed ID: 8115932
    [No Abstract]   [Full Text] [Related]  

  • 9. Discordance between fetal RhD typing using molecular methods and neonatal typing with serology.
    Van Den Veyver IB; Yankowitz J; Subramanian SB; Dorman KF; Moise KJ
    Gynecol Obstet Invest; 1999; 48(4):229-31. PubMed ID: 10592422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhD typing and the significance of Du.
    Needs ME
    Br J Biomed Sci; 2000; 57(4):339. PubMed ID: 11204868
    [No Abstract]   [Full Text] [Related]  

  • 11. [External national quality control of blood group typing 1983-92. Significance for quality assurance in transfusion medicine].
    Heier HE; Kornstad L
    Tidsskr Nor Laegeforen; 1993 Oct; 113(25):3155-8. PubMed ID: 8273042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHD genotyping and its implication in transfusion practice.
    Sassi A; Ouchari M; Houissa B; Romdhane H; Abdelkefi S; Chakroun T; Jemni Yacoub S
    Transfus Apher Sci; 2014 Dec; 51(3):59-63. PubMed ID: 25457010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal RhD typing by DNA amplification in chorionic villus sample.
    Brambati B; Anelli MC; Tului L; Colombo G
    Lancet; 1994 Oct; 344(8927):959-60. PubMed ID: 7934375
    [No Abstract]   [Full Text] [Related]  

  • 14. Fetal RhD typing with free DNA in maternal plasma.
    Moise KJ
    Am J Obstet Gynecol; 2005 Mar; 192(3):663-5. PubMed ID: 15746655
    [No Abstract]   [Full Text] [Related]  

  • 15. Raising the sensitivity of fetal RhD typing and sex determination from maternal blood.
    Hengstschläger M; Hölzl G; Ulm B; Bernaschek G
    J Med Genet; 1997 Apr; 34(4):350-1. PubMed ID: 9138165
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.
    Gowland P; Gassner C; Hustinx H; Stolz M; Gottschalk J; Tissot JD; Thierbach J; Maier A; Sigurdardottir S; Still F; Fontana S; Frey BM; Niederhauser C
    Transfus Apher Sci; 2014 Apr; 50(2):163-8. PubMed ID: 24656493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serology and genetics of weak D types in Denmark.
    Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
    Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RHD DNA screening for weak D, DEL and D+/- 'chimeras'.
    Gassner C; Rozman P
    Vox Sang; 2006 Aug; 91(2):184. PubMed ID: 16907882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocyte blood group in cord blood].
    Gallet M; Brulé-Pépin R; Omanga-Léké ML; Lorriaux C
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):512. PubMed ID: 12379837
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.